Abstract

Several studies have shown that 65 % of expanded poly (tetrafluoroethylene) (ePTFE) vascular prostheses had to be explanted within 10 years of implantation in humans. The reasons for these explantations relied on thrombosis formation and poor hemocompatibility of synthetic polymers. It has been shown that surface modification of ePTFE arterial prostheses could enable their endothelialization therefore improving their biocompatibility and hemocompatibility. Indeed, endothelial cells naturally cover the biological blood vessel wall and consequently, an endothelial layer constitutes the best achievable hemocompatible surface. In this context, our strategy consisted in micropatterning cell adhesion (RGD) and proliferation (WQPPRARI) peptides on the surface of plasma-functionalized PTFE, therefore enabling covalent conjugation of the peptides. Basically, the technology consisted in spraying a solution of the adhesion peptide, therefore leading to 10 µm-diameter RGD spots semi-randomly distributed over the sample and covering 20 % of the whole polymer surface. In a second step, proliferation peptide was applied to the remaining surface by soaking, therefore covering the unreacted surface. The 20 % coverage was obtained by using an x-y table, programmed to move from side to side of the surface on x value, with an increment on y value that has been calibrated.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.